Almanac Health, a research-validated clinical AI platform and evidence-based clinical decision support company founded by physician-researcher Cyril Zakka, MD, whose work at Stanford introduced retrieval-augmented generation to clinical medicine, has raised $10 million in a seed round led by F-Prime, with participation from General Catalyst and Lightspeed Venture Partners. General Catalyst previously led the company's pre-seed round with participation from Soma Capital. This financing brings Almanac Health's total funding to nearly $12 million and will accelerate the company's mission to bring safe, evidence-grounded AI to clinicians and health systems.

Almanac Health is a clinical AI platform that brings specialist-grade knowledge to clinicians at the point of care, providing evidence-based clinical decision support across medical specialties, free from pharmaceutical advertising, and governed by institutional controls. The platform integrates with existing EHR systems and is clinically validated through peer-reviewed research.